Loading...
Should we treat acute hepatitis C? A decision and cost-effectiveness analysis
It is not standard practice to treat patients with acute hepatitis C virus (HCV) infection. However, as the incidence of HCV in the United States continues to rise, it may be time to re-evaluate acute HCV management in the era of direct-acting antiviral agents (DAAs). In this study a microsimulation...
Na minha lista:
| Udgivet i: | Hepatology |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5826841/ https://ncbi.nlm.nih.gov/pubmed/29059461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.29611 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|